BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides 2020;124:170223. [DOI: 10.1016/j.peptides.2019.170223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Junkins MS, Bagriantsev SN, Gracheva EO. Towards understanding the neural origins of hibernation. J Exp Biol 2022;225:jeb229542. [PMID: 34982152 DOI: 10.1242/jeb.229542] [Reference Citation Analysis]
2 Redkiewicz P, Dyniewicz J, Misicka A. Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases? Int J Mol Sci 2021;22:11347. [PMID: 34768778 DOI: 10.3390/ijms222111347] [Reference Citation Analysis]
3 Zhang S, Yang F, Shi R, Liu C, Zhao L, Gu X, Liu Y, Fu F, Feng N, Liu Y, Jia M, Fan R, Yang L, Li J, Li J, Pei J. Activation of κ-opioid receptor inhibits inflammatory response induced by sodium palmitate in human umbilical vein endothelial cells. Cytokine 2021;146:155659. [PMID: 34332276 DOI: 10.1016/j.cyto.2021.155659] [Reference Citation Analysis]
4 Chen M, Zhang X, Fan J, Sun H, Yao Q, Shi J, Qu H, Du S, Cheng Y, Ma S, Zhang M, Zhan S. Dynorphin A (1-8) inhibits oxidative stress and apoptosis in MCAO rats, affording neuroprotection through NMDA receptor and κ-opioid receptor channels. Neuropeptides 2021;89:102182. [PMID: 34298371 DOI: 10.1016/j.npep.2021.102182] [Reference Citation Analysis]
5 Shafi A, Berry AJ, Sumnall H, Wood DM, Tracy DK. New psychoactive substances: a review and updates. Ther Adv Psychopharmacol 2020;10:2045125320967197. [PMID: 33414905 DOI: 10.1177/2045125320967197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
6 Martínez V, Abalo R. Peripherally acting opioid analgesics and peripherally-induced analgesia. Behav Pharmacol 2020;31:136-58. [PMID: 32168025 DOI: 10.1097/FBP.0000000000000558] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Talhami A, Swed A, Hess S, Ovadia O, Greenberg S, Schumacher-Klinger A, Rosenthal D, Shalev DE, Hurevich M, Lazarovici P, Hoffman A, Gilon C. Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs. Front Chem 2020;8:532577. [PMID: 33282822 DOI: 10.3389/fchem.2020.532577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Pol O. The role of carbon monoxide, heme oxygenase 1, and the Nrf2 transcription factor in the modulation of chronic pain and their interactions with opioids and cannabinoids. Med Res Rev 2021;41:136-55. [PMID: 32820550 DOI: 10.1002/med.21726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
9 Berthiaume S, Abdallah K, Blais V, Gendron L. Alleviating pain with delta opioid receptor agonists: evidence from experimental models. J Neural Transm (Vienna) 2020;127:661-72. [PMID: 32189076 DOI: 10.1007/s00702-020-02172-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]